The importance of appropriate treatment of chronic bronchitis

American Journal of Managed Care

Volumn 6, Issue 8 SUPPL., 2000, Pages

  Anzueto, Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

BACTERIAL INFECTION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST OF ILLNESS; DISEASE EXACERBATION; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HUMAN; MORAXELLA CATARRHALIS; NOTE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; BRONCHITIS; CHRONIC DISEASE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; PREVALENCE; UNITED STATES;

EID: 0343238864     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 1999;21:576-591.
2. Lundback B, Nystrom L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden; respiratory symptoms assessed in a postal survey. Eur Respir J 1991;4:257-266.
3. Viegi G, Paoletti P, Carrozzi L, et al. Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of pollution. Environ Health Perspect 1991;94:95-99.
4. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154(4 Pt 1): 959-967.
5. Fagon JY, Chastre J, Trouillet JL, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990;142: 1004-1008.
6. DeAbate CA, Henry D, Beusch G, et al. Sparfloxacin vs ofloxacin in the treatment of acute exacerbations of chronic bronchitis. A multicenter, double-blind, randomized, comparative study. Chest 1998;114:120-130.
7. Adams S, Melo J, Anzueto A. Effect of antibiotics on the recurrence rates of chronic obstructive pulmonary disease exacerbations. Chest. In press.
8. Destache CJ, Dewan N, O'Donohue WJ, Campbell JC, Angelillo VA. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1999;43:107-113.
9. Grossman R, Mukherjee J, Vaughan D, et al. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: The Canadian Ciprofloxacin Health Economic Study Group. Chest 1998;113:131-141.